Get the app
US › Healthcare

LifeMD Inc (LFMD)

US · Healthcare · Health Information Services

$2.34-4.88%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$47.3M
Revenue YoY
-24.0%
Net profit
$-7.1M
EPS
$-0.16
EPS estimate
$-0.20
Net margin
-15.0%

EPS came in at -0.16 against a street estimate of -0.20 — a beat of 20.0%.

Key statistics

Market cap
$119.2M
Forward P/E
12.9
P/B
18.48
Book value
$0.17
EPS (TTM)
$-0.51
52-week high
$6.53
52-week low
$2.36
50-day MA
$3.16
200-day MA
$3.77
Beta
1.99

Analyst view

Analysts rate LifeMD Inc a strong buy (8 buy, 0 hold, 0 sell out of 8) with an average price target of $8.12.

Shareholding

Insiders
15.80%
Institutions
47.39%

Largest institutional holders

FundStake
BlackRock Inc6.29%
Federated Hermes Inc5.69%
Vanguard Capital Management, LLC3.59%
State Street Corp2.73%
Renaissance Technologies Corp2.24%
Geode Capital Management, LLC2.21%
Prescott Group Capital Management LLC1.86%
BRC Group Holdings Inc1.32%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for LifeMD Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.